Increase in U.S. Tech M&A Activity Under Ferguson's FTC by End of 2025?
Yes • 50%
No • 50%
Publicly available data on M&A activity from financial news outlets and reports
Trump Appoints Ferguson as FTC Chair, Signals Pro-Business Shift
Dec 11, 2024, 02:42 PM
President-elect Donald Trump has announced his intention to appoint Andrew Ferguson as the new chair of the Federal Trade Commission (FTC), replacing Lina Khan. This move is seen as part of Trump's broader strategy to reshape the regulatory landscape, particularly in relation to Big Tech, as he prepares for his second term. Market analysts and bankers anticipate a more favorable environment for mergers and acquisitions (M&A) under Ferguson's leadership, with expectations of increased dealmaking in the U.S. as the new administration takes office. Ferguson, known for his advocacy of free speech and a pro-business stance, is expected to steer the FTC away from what some describe as partisan culture. His appointment has sparked discussions about potential changes in antitrust enforcement, with some predicting a more lenient approach towards Big Tech companies like Google, Meta, Microsoft, and Amazon, which could lead to significant M&A activity. Mark Meador has also been nominated as a commissioner, further signaling a shift in the FTC's direction.
View original story
Increased competition • 25%
Other • 25%
No significant change • 25%
Decreased competition • 25%
Amazon • 25%
Meta • 25%
Microsoft • 25%
Other • 25%
No • 50%
Yes • 50%
No action taken • 25%
Formal warnings issued • 25%
Restrictions imposed • 25%
Lawsuits filed • 25%
Increased focus on online censorship • 25%
Focus on consumer privacy • 25%
No significant policy change • 25%
Focus on antitrust issues • 25%
Other • 25%
Retail • 25%
Biopharma • 25%
Technology • 25%
Other • 25%
Antitrust enforcement • 25%
Consumer protection • 25%
Big Tech regulation • 25%
Severe Misconduct Found • 25%
Significant Misconduct Found • 25%
Minor Misconduct Found • 25%
No Misconduct Found • 25%
Antitrust actions • 25%
No significant actions • 25%
Increased regulation • 25%
Other • 25%
Policy Reversal • 25%
Increased Mergers • 25%
No Change • 25%
Decreased Mergers • 25%
Pharmaceutical Regulation • 25%
Consumer Protection • 25%
Antitrust Enforcement • 25%
Big Tech Regulation • 25%
Less aggressive • 25%
More aggressive • 25%
Other • 25%
No change • 25%
No significant change • 25%
Other • 25%
Stricter regulation • 25%
More lenient regulation • 25%